NovoNorm and Zeffix generics pass CHMP scrutiny
30 July 2009
James Mills
The EU's
CHMP issued positive opinions on centralised marketing authorisation applications from
Krka for two NovoNorm (repaglinide) generics at its July meeting last week. Applications from
Teva Pharmaceutical Industries and
Mylan for different generic products were also recommended for approval.
Krka's...
Please Login to read the full article.
30 July 2009
James Mills
Krka's...
Please Login to read the full article.
RELATED CONTENT
NEWS
- CHMP opines positively on Dificlir, hypertension and diabetes combos, but restricts Multaq
- Dainippon Sumitomo diabetes re-jig sees pipeline casualties
- Brilique beats rival clopidogrel for ACS: now NICE would like Efient comparison
- Sanofi results: Genzyme doesn't paper over cracks, as emerging markets top US and EU
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
